Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population

Paula Silva Felicio; Lucas Tadeu Bidinotto; Matias Eliseo Melendez; Rebeca Silveira Grasel; Natalia Campacci; Henrique C.R. Galvão; Cristovam Scapulatempo-Neto; Rozany Mucha Dufloth; Adriane Feijó Evangelista; Edenir Inêz Palmero

doi:10.18632/oncotarget.25537

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population

Paula Silva Felicio, Lucas Tadeu Bidinotto, Matias Eliseo Melendez, Rebeca Silveira Grasel, Natalia Campacci, Henrique C.R. Galvão, Cristovam Scapulatempo-Neto, Rozany Mucha Dufloth, Adriane Feijó Evangelista and Edenir Inêz Palmero _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2018; 9:27525-27534. https://doi.org/10.18632/oncotarget.25537

Metrics: PDF 1386 views | HTML 3354 views | ?

Abstract

Paula Silva Felicio1, Lucas Tadeu Bidinotto1,2, Matias Eliseo Melendez1, Rebeca Silveira Grasel1, Natalia Campacci1, Henrique C.R. Galvão3, Cristovam Scapulatempo-Neto4, Rozany Mucha Dufloth4, Adriane Feijó Evangelista1 and Edenir Inêz Palmero1,2

1Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil

2Barretos School of Health Sciences-FACISB, Barretos, SP, Brazil

3Department of Oncogenetics, Barretos Cancer Hospital, Barretos, SP, Brazil

4Department of Pathology, Barretos Cancer Hospital, Barretos, SP, Brazil

Correspondence to:

Edenir Inêz Palmero, email: [email protected]

Keywords: BRCAX; hereditary breast cancer; hereditary breast and ovarian cancer predisposition syndrome; CNV alterations

Received: August 09, 2017 Accepted: May 14, 2018 Published: June 08, 2018

ABSTRACT

Background: About 5–10% of breast/ovarian cancers are hereditary. However, for a large proportion of cases (around 50%), the genetic cause remains unknown. These cases are grouped in a separated BRCAX category. The aim of this study was to identify genomic alterations in BRCA1/BRCA2 wild-type tumor samples from women with family history strongly suggestive of hereditary breast/ovarian cancer.

Results: A cohort of 31 Brazilian women was included in the study. Using the GISTIC algorithm, we identified 20 regions with genomic gains and 31 with losses. The most frequent altered regions were 1q21.2, 6p22.1 and 8p23.3 in breast tumors and Xq26 and Xp22.32-22.31 among the ovarian cancer cases. An interesting association identified was the loss of 22q13.31-13.32 and the presence of ovarian cancer cases. Among the genes present in the frequently altered regions, we found FGFR1, NSMCE2, CTTN, CRLF2, ERBB2, STARD3, MIR3201 and several genes of RAET and ULBP family.

Conclusions: In conclusion, our results suggest that alterations on chromosomes 1, 6, 8 and X are common on BRCAX tumors and that the loss on 22q can be associated with the presence of ovarian cancer.

Methods: DNA copy number alterations were analyzed by 60K array comparative genomic hybridization in breast and ovarian FFPE tumors.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 25537

Publication Alerts

Research Papers:

Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population

Abstract